AEON Biopharma, Inc. (AEON)
USD 0.67
(2.31%)
USD 0.67
(2.31%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | -35.58 Million | -28.43 Million | -9.46 Million | -44.72 Million |
| Net Income | -52.55 Million | -55.63 Million | -32.91 Million | 160.31 Million |
| Depreciation & Amortization | 68 Thousand | 3000.00 | - | 1.25 Million |
| Deferred income taxes | 4.74 Million | 1.18 Million | - | -14.64 Million |
| Stock-based compensation | 5.89 Million | 5.22 Million | 4.79 Million | 5.25 Million |
| Change in working capital | 6.26 Million | 1.41 Million | 1.45 Million | 50 Thousand |
| Other non-cash items | -3000.00 | 19.38 Million | 17.2 Million | -196.95 Million |
| Investing Cash Flow | -306 Thousand | -170 Thousand | -1.26 Million | -117.29 Million |
| Investments in PPE | -306 Thousand | -170 Thousand | - | -1.69 Million |
| Acquisitions | - | - | -1.26 Million | -36.52 Million |
| Investment purchases | - | - | - | -89.06 Million |
| Sales/Maturities of investments | - | - | - | 10 Million |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 40.5 Million | 13.56 Million | 24.57 Million | 73.21 Million |
| Debt repayment | -3.99 Million | -15 Million | -300 Thousand | -74.22 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | -64 Thousand |
| Common Stock Issuance | - | - | - | 77.79 Million |
| Other Financing Activities | 44.5 Million | 13.56 Million | 24.87 Million | 153.61 Million |
| Accounts receivables | - | - | -148 Thousand | -24 Thousand |
| Accounts payables | 6.61 Million | -898 Thousand | 667 Thousand | 3.92 Million |
| Inventory | - | - | - | -7.39 Million |
| Other working capital | -345 Thousand | 2.31 Million | 933 Thousand | 3.54 Million |
| Cash at beginning of period | 5.12 Million | 20.16 Million | 6.32 Million | 95.12 Million |
| Cash at end of period | 9.74 Million | 5.12 Million | 20.16 Million | 6.32 Million |
| Capital Expenditure | -306 Thousand | -170 Thousand | - | -1.69 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 4.61 Million | -15.04 Million | 13.84 Million | -88.8 Million |
| Free Cash Flow | -35.89 Million | -28.6 Million | -9.46 Million | -46.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 164.11 Million | -118.01 Million | -15.37 Million | -17.63 Million | -34.56 Million | -52.55 Million |
| Depreciation & Amortization | 24 Thousand | 25 Thousand | 23 Thousand | 25 Thousand | 32 Thousand | 68 Thousand |
| Deferred income taxes | - | - | - | - | - | 4.74 Million |
| Stock-based compensation | 1.69 Million | 1.62 Million | 1.14 Million | 1.36 Million | 1.66 Million | 5.89 Million |
| Change in working capital | -2.1 Million | 96 Thousand | 2.67 Million | 539 Thousand | 4.73 Million | 6.26 Million |
| Other non-cash items | -163.02 Million | 63.85 Million | 1.45 Million | 4.65 Million | 19.67 Million | -3000.00 |
| Investing Cash Flow | - | - | - | - | -9000.00 | -306 Thousand |
| Investments in PPE | - | - | - | - | -9000.00 | -306 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 10 Million | 5 Million | 8 Million | 6 Million | -3.99 Million | 40.5 Million |
| Debt repayment | -10 Million | -5 Million | -8 Million | -6 Million | -3.99 Million | -3.99 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 44.5 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.49 Million | 3.13 Million | 2.06 Million | -3.52 Million | 5.18 Million | 6.61 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 58 Thousand | 64 Thousand | -57 Thousand | 40 Thousand | -445 Thousand | -345 Thousand |
| Cash at beginning of period | 1.55 Million | 5.15 Million | 4.68 Million | 9.74 Million | 22.2 Million | 5.12 Million |
| Cash at end of period | 3.44 Million | 1.55 Million | 2.6 Million | 4.68 Million | 9.74 Million | 9.74 Million |
| Capital Expenditure | - | - | - | - | -9000.00 | -306 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.88 Million | -3.6 Million | -2.08 Million | -5.05 Million | -12.45 Million | 4.61 Million |
| Free Cash Flow | -8.11 Million | -8.6 Million | -10.08 Million | -11.05 Million | -8.46 Million | -35.89 Million |
9898
EMU
CAT
ACM
SHELTER
6637